Global Antipsychotic Drug Market Research Report 2022 - Market Study Report

Global Antipsychotic Drug Market Research Report 2022

Report Format: PDF   |   Report ID: 5514201   |   Published Date: August 2022   |   Pages:  107  

Choose License
Highlights
The global Antipsychotic Drug market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Antipsychotic Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Antipsychotic Drug is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The global market for Antipsychotic Drug in Bipolar I Disorder is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global companies of Antipsychotic Drug include Johnson & Johnson, Pfizer, Eli Lilly, Bristol Myers Squibb, AstraZeneca, Sumitomo Dainippon Pharma, Allergan, Novartis and Cardinal Health, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19, First Generation Antipsychotics Drug, which accounted for % of the global market of Antipsychotic Drug in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of  % from 2022 to 2028. 
Report Scope
This report aims to provide a comprehensive presentation of the global market for Antipsychotic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antipsychotic Drug.
The Antipsychotic Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Antipsychotic Drug market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antipsychotic Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
    Johnson & Johnson
    Pfizer
    Eli Lilly
    Bristol Myers Squibb
    AstraZeneca
    Sumitomo Dainippon Pharma
    Allergan
    Novartis
    Cardinal Health
    Sun Pharmaceutical Industries
    GlaxoSmithKline
    Sanis Health
    Qilu Pharmaceutical
    Otsuka Pharmaceutical
    Vanda Pharmaceuticals
    H.Lundbeck
    Organon
    Hansoh
    Hengrui
    Nhwa Group
    Yangtze River Pharmaceutical Group
Product Type Insights
Global markets are presented by Antipsychotic Drug type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Antipsychotic Drug are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Antipsychotic Drug segment by Type
    First Generation Antipsychotics Drug
    Second Generation Antipsychotics Drug
    Third generation Antipsychotics Drug
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Antipsychotic Drug market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Antipsychotic Drug market.
Antipsychotic Drug Segment by Application
    Bipolar I Disorder
    Schizophrenia
    Schizoaffective Disorder
    Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Antipsychotic Drug market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antipsychotic Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Antipsychotic Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Antipsychotic Drug industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antipsychotic Drug.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antipsychotic Drug companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Antipsychotic Drug Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 First Generation Antipsychotics Drug
        1.2.3 Second Generation Antipsychotics Drug
        1.2.4 Third generation Antipsychotics Drug
    1.3 Market by Application
        1.3.1 Global Antipsychotic Drug Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Bipolar I Disorder
        1.3.3 Schizophrenia
        1.3.4 Schizoaffective Disorder
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Antipsychotic Drug Market Perspective (2017-2028)
    2.2 Antipsychotic Drug Growth Trends by Region
        2.2.1 Antipsychotic Drug Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Antipsychotic Drug Historic Market Size by Region (2017-2022)
        2.2.3 Antipsychotic Drug Forecasted Market Size by Region (2023-2028)
    2.3 Antipsychotic Drug Market Dynamics
        2.3.1 Antipsychotic Drug Industry Trends
        2.3.2 Antipsychotic Drug Market Drivers
        2.3.3 Antipsychotic Drug Market Challenges
        2.3.4 Antipsychotic Drug Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Antipsychotic Drug Players by Revenue
        3.1.1 Global Top Antipsychotic Drug Players by Revenue (2017-2022)
        3.1.2 Global Antipsychotic Drug Revenue Market Share by Players (2017-2022)
    3.2 Global Antipsychotic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Antipsychotic Drug Revenue
    3.4 Global Antipsychotic Drug Market Concentration Ratio
        3.4.1 Global Antipsychotic Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Antipsychotic Drug Revenue in 2021
    3.5 Antipsychotic Drug Key Players Head office and Area Served
    3.6 Key Players Antipsychotic Drug Product Solution and Service
    3.7 Date of Enter into Antipsychotic Drug Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Antipsychotic Drug Breakdown Data by Type
    4.1 Global Antipsychotic Drug Historic Market Size by Type (2017-2022)
    4.2 Global Antipsychotic Drug Forecasted Market Size by Type (2023-2028)
5 Antipsychotic Drug Breakdown Data by Application
    5.1 Global Antipsychotic Drug Historic Market Size by Application (2017-2022)
    5.2 Global Antipsychotic Drug Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Antipsychotic Drug Market Size (2017-2028)
    6.2 North America Antipsychotic Drug Market Size by Country (2017-2022)
    6.3 North America Antipsychotic Drug Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Antipsychotic Drug Market Size (2017-2028)
    7.2 Europe Antipsychotic Drug Market Size by Country (2017-2022)
    7.3 Europe Antipsychotic Drug Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Antipsychotic Drug Market Size (2017-2028)
    8.2 Asia-Pacific Antipsychotic Drug Market Size by Country (2017-2022)
    8.3 Asia-Pacific Antipsychotic Drug Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Antipsychotic Drug Market Size (2017-2028)
    9.2 Latin America Antipsychotic Drug Market Size by Country (2017-2022)
    9.3 Latin America Antipsychotic Drug Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Antipsychotic Drug Market Size (2017-2028)
    10.2 Middle East & Africa Antipsychotic Drug Market Size by Country (2017-2022)
    10.3 Middle East & Africa Antipsychotic Drug Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Johnson & Johnson
        11.1.1 Johnson & Johnson Company Detail
        11.1.2 Johnson & Johnson Business Overview
        11.1.3 Johnson & Johnson Antipsychotic Drug Introduction
        11.1.4 Johnson & Johnson Revenue in Antipsychotic Drug Business (2017-2022)
        11.1.5 Johnson & Johnson Recent Development
    11.2 Pfizer
        11.2.1 Pfizer Company Detail
        11.2.2 Pfizer Business Overview
        11.2.3 Pfizer Antipsychotic Drug Introduction
        11.2.4 Pfizer Revenue in Antipsychotic Drug Business (2017-2022)
        11.2.5 Pfizer Recent Development
    11.3 Eli Lilly
        11.3.1 Eli Lilly Company Detail
        11.3.2 Eli Lilly Business Overview
        11.3.3 Eli Lilly Antipsychotic Drug Introduction
        11.3.4 Eli Lilly Revenue in Antipsychotic Drug Business (2017-2022)
        11.3.5 Eli Lilly Recent Development
    11.4 Bristol Myers Squibb
        11.4.1 Bristol Myers Squibb Company Detail
        11.4.2 Bristol Myers Squibb Business Overview
        11.4.3 Bristol Myers Squibb Antipsychotic Drug Introduction
        11.4.4 Bristol Myers Squibb Revenue in Antipsychotic Drug Business (2017-2022)
        11.4.5 Bristol Myers Squibb Recent Development
    11.5 AstraZeneca
        11.5.1 AstraZeneca Company Detail
        11.5.2 AstraZeneca Business Overview
        11.5.3 AstraZeneca Antipsychotic Drug Introduction
        11.5.4 AstraZeneca Revenue in Antipsychotic Drug Business (2017-2022)
        11.5.5 AstraZeneca Recent Development
    11.6 Sumitomo Dainippon Pharma
        11.6.1 Sumitomo Dainippon Pharma Company Detail
        11.6.2 Sumitomo Dainippon Pharma Business Overview
        11.6.3 Sumitomo Dainippon Pharma Antipsychotic Drug Introduction
        11.6.4 Sumitomo Dainippon Pharma Revenue in Antipsychotic Drug Business (2017-2022)
        11.6.5 Sumitomo Dainippon Pharma Recent Development
    11.7 Allergan
        11.7.1 Allergan Company Detail
        11.7.2 Allergan Business Overview
        11.7.3 Allergan Antipsychotic Drug Introduction
        11.7.4 Allergan Revenue in Antipsychotic Drug Business (2017-2022)
        11.7.5 Allergan Recent Development
    11.8 Novartis
        11.8.1 Novartis Company Detail
        11.8.2 Novartis Business Overview
        11.8.3 Novartis Antipsychotic Drug Introduction
        11.8.4 Novartis Revenue in Antipsychotic Drug Business (2017-2022)
        11.8.5 Novartis Recent Development
    11.9 Cardinal Health
        11.9.1 Cardinal Health Company Detail
        11.9.2 Cardinal Health Business Overview
        11.9.3 Cardinal Health Antipsychotic Drug Introduction
        11.9.4 Cardinal Health Revenue in Antipsychotic Drug Business (2017-2022)
        11.9.5 Cardinal Health Recent Development
    11.10 Sun Pharmaceutical Industries
        11.10.1 Sun Pharmaceutical Industries Company Detail
        11.10.2 Sun Pharmaceutical Industries Business Overview
        11.10.3 Sun Pharmaceutical Industries Antipsychotic Drug Introduction
        11.10.4 Sun Pharmaceutical Industries Revenue in Antipsychotic Drug Business (2017-2022)
        11.10.5 Sun Pharmaceutical Industries Recent Development
    11.11 GlaxoSmithKline
        11.11.1 GlaxoSmithKline Company Detail
        11.11.2 GlaxoSmithKline Business Overview
        11.11.3 GlaxoSmithKline Antipsychotic Drug Introduction
        11.11.4 GlaxoSmithKline Revenue in Antipsychotic Drug Business (2017-2022)
        11.11.5 GlaxoSmithKline Recent Development
    11.12 Sanis Health
        11.12.1 Sanis Health Company Detail
        11.12.2 Sanis Health Business Overview
        11.12.3 Sanis Health Antipsychotic Drug Introduction
        11.12.4 Sanis Health Revenue in Antipsychotic Drug Business (2017-2022)
        11.12.5 Sanis Health Recent Development
    11.13 Qilu Pharmaceutical
        11.13.1 Qilu Pharmaceutical Company Detail
        11.13.2 Qilu Pharmaceutical Business Overview
        11.13.3 Qilu Pharmaceutical Antipsychotic Drug Introduction
        11.13.4 Qilu Pharmaceutical Revenue in Antipsychotic Drug Business (2017-2022)
        11.13.5 Qilu Pharmaceutical Recent Development
    11.14 Otsuka Pharmaceutical
        11.14.1 Otsuka Pharmaceutical Company Detail
        11.14.2 Otsuka Pharmaceutical Business Overview
        11.14.3 Otsuka Pharmaceutical Antipsychotic Drug Introduction
        11.14.4 Otsuka Pharmaceutical Revenue in Antipsychotic Drug Business (2017-2022)
        11.14.5 Otsuka Pharmaceutical Recent Development
    11.15 Vanda Pharmaceuticals
        11.15.1 Vanda Pharmaceuticals Company Detail
        11.15.2 Vanda Pharmaceuticals Business Overview
        11.15.3 Vanda Pharmaceuticals Antipsychotic Drug Introduction
        11.15.4 Vanda Pharmaceuticals Revenue in Antipsychotic Drug Business (2017-2022)
        11.15.5 Vanda Pharmaceuticals Recent Development
    11.16 H.Lundbeck
        11.16.1 H.Lundbeck Company Detail
        11.16.2 H.Lundbeck Business Overview
        11.16.3 H.Lundbeck Antipsychotic Drug Introduction
        11.16.4 H.Lundbeck Revenue in Antipsychotic Drug Business (2017-2022)
        11.16.5 H.Lundbeck Recent Development
    11.17 Organon
        11.17.1 Organon Company Detail
        11.17.2 Organon Business Overview
        11.17.3 Organon Antipsychotic Drug Introduction
        11.17.4 Organon Revenue in Antipsychotic Drug Business (2017-2022)
        11.17.5 Organon Recent Development
    11.18 Hansoh
        11.18.1 Hansoh Company Detail
        11.18.2 Hansoh Business Overview
        11.18.3 Hansoh Antipsychotic Drug Introduction
        11.18.4 Hansoh Revenue in Antipsychotic Drug Business (2017-2022)
        11.18.5 Hansoh Recent Development
    11.19 Hengrui
        11.19.1 Hengrui Company Detail
        11.19.2 Hengrui Business Overview
        11.19.3 Hengrui Antipsychotic Drug Introduction
        11.19.4 Hengrui Revenue in Antipsychotic Drug Business (2017-2022)
        11.19.5 Hengrui Recent Development
    11.20 Nhwa Group
        11.20.1 Nhwa Group Company Detail
        11.20.2 Nhwa Group Business Overview
        11.20.3 Nhwa Group Antipsychotic Drug Introduction
        11.20.4 Nhwa Group Revenue in Antipsychotic Drug Business (2017-2022)
        11.20.5 Nhwa Group Recent Development
    11.21 Yangtze River Pharmaceutical Group
        11.21.1 Yangtze River Pharmaceutical Group Company Detail
        11.21.2 Yangtze River Pharmaceutical Group Business Overview
        11.21.3 Yangtze River Pharmaceutical Group Antipsychotic Drug Introduction
        11.21.4 Yangtze River Pharmaceutical Group Revenue in Antipsychotic Drug Business (2017-2022)
        11.21.5 Yangtze River Pharmaceutical Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables Table 1. Global Antipsychotic Drug Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of First Generation Antipsychotics Drug Table 3. Key Players of Second Generation Antipsychotics Drug Table 4. Key Players of Third generation Antipsychotics Drug Table 5. Global Antipsychotic Drug Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Antipsychotic Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Antipsychotic Drug Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Antipsychotic Drug Market Share by Region (2017-2022) Table 9. Global Antipsychotic Drug Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Antipsychotic Drug Market Share by Region (2023-2028) Table 11. Antipsychotic Drug Market Trends Table 12. Antipsychotic Drug Market Drivers Table 13. Antipsychotic Drug Market Challenges Table 14. Antipsychotic Drug Market Restraints Table 15. Global Antipsychotic Drug Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Antipsychotic Drug Market Share by Players (2017-2022) Table 17. Global Top Antipsychotic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antipsychotic Drug as of 2021) Table 18. Ranking of Global Top Antipsychotic Drug Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Antipsychotic Drug Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Antipsychotic Drug Product Solution and Service Table 22. Date of Enter into Antipsychotic Drug Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Antipsychotic Drug Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Antipsychotic Drug Revenue Market Share by Type (2017-2022) Table 26. Global Antipsychotic Drug Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Antipsychotic Drug Revenue Market Share by Type (2023-2028) Table 28. Global Antipsychotic Drug Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Antipsychotic Drug Revenue Market Share by Application (2017-2022) Table 30. Global Antipsychotic Drug Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Antipsychotic Drug Revenue Market Share by Application (2023-2028) Table 32. North America Antipsychotic Drug Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Antipsychotic Drug Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Antipsychotic Drug Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Antipsychotic Drug Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Antipsychotic Drug Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Antipsychotic Drug Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Antipsychotic Drug Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Antipsychotic Drug Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Antipsychotic Drug Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Antipsychotic Drug Market Size by Country (2023-2028) & (US$ Million) Table 42. Johnson & Johnson Company Detail Table 43. Johnson & Johnson Business Overview Table 44. Johnson & Johnson Antipsychotic Drug Product Table 45. Johnson & Johnson Revenue in Antipsychotic Drug Business (2017-2022) & (US$ Million) Table 46. Johnson & Johnson Recent Development Table 47. Pfizer Company Detail Table 48. Pfizer Business Overview Table 49. Pfizer Antipsychotic Drug Product Table 50. Pfizer Revenue in Antipsychotic Drug Business (2017-2022) & (US$ Million) Table 51. Pfizer Recent Development Table 52. Eli Lilly Company Detail Table 53. Eli Lilly Business Overview Table 54. Eli Lilly Antipsychotic Drug Product Table 55. Eli Lilly Revenue in Antipsychotic Drug Business (2017-2022) & (US$ Million) Table 56. Eli Lilly Recent Development Table 57. Bristol Myers Squibb Company Detail Table 58. Bristol Myers Squibb Business Overview Table 59. Bristol Myers Squibb Antipsychotic Drug Product Table 60. Bristol Myers Squibb Revenue in Antipsychotic Drug Business (2017-2022) & (US$ Million) Table 61. Bristol Myers Squibb Recent Development Table 62. AstraZeneca Company Detail Table 63. AstraZeneca Business Overview Table 64. AstraZeneca Antipsychotic Drug Product Table 65. AstraZeneca Revenue in Antipsychotic Drug Business (2017-2022) & (US$ Million) Table 66. AstraZeneca Recent Development Table 67. Sumitomo Dainippon Pharma Company Detail Table 68. Sumitomo Dainippon Pharma Business Overview Table 69. Sumitomo Dainippon Pharma Antipsychotic Drug Product Table 70. Sumitomo Dainippon Pharma Revenue in Antipsychotic Drug Business (2017-2022) & (US$ Million) Table 71. Sumitomo Dainippon Pharma Recent Development Table 72. Allergan Company Detail Table 73. Allergan Business Overview Table 74. Allergan Antipsychotic Drug Product Table 75. Allergan Revenue in Antipsychotic Drug Business (2017-2022) & (US$ Million) Table 76. Allergan Recent Development Table 77. Novartis Company Detail Table 78. Novartis Business Overview Table 79. Novartis Antipsychotic Drug Product Table 80. Novartis Revenue in Antipsychotic Drug Business (2017-2022) & (US$ Million) Table 81. Novartis Recent Development Table 82. Cardinal Health Company Detail Table 83. Cardinal Health Business Overview Table 84. Cardinal Health Antipsychotic Drug Product Table 85. Cardinal Health Revenue in Antipsychotic Drug Business (2017-2022) & (US$ Million) Table 86. Cardinal Health Recent Development Table 87. Sun Pharmaceutical Industries Company Detail Table 88. Sun Pharmaceutical Industries Business Overview Table 89. Sun Pharmaceutical Industries Antipsychotic Drug Product Table 90. Sun Pharmaceutical Industries Revenue in Antipsychotic Drug Business (2017-2022) & (US$ Million) Table 91. Sun Pharmaceutical Industries Recent Development Table 92. GlaxoSmithKline Company Detail Table 93. GlaxoSmithKline Business Overview Table 94. GlaxoSmithKline Antipsychotic DrugProduct Table 95. GlaxoSmithKline Revenue in Antipsychotic Drug Business (2017-2022) & (US$ Million) Table 96. GlaxoSmithKline Recent Development Table 97. Sanis Health Company Detail Table 98. Sanis Health Business Overview Table 99. Sanis Health Antipsychotic DrugProduct Table 100. Sanis Health Revenue in Antipsychotic Drug Business (2017-2022) & (US$ Million) Table 101. Sanis Health Recent Development Table 102. Qilu Pharmaceutical Company Detail Table 103. Qilu Pharmaceutical Business Overview Table 104. Qilu Pharmaceutical Antipsychotic DrugProduct Table 105. Qilu Pharmaceutical Revenue in Antipsychotic Drug Business (2017-2022) & (US$ Million) Table 106. Qilu Pharmaceutical Recent Development Table 107. Otsuka Pharmaceutical Company Detail Table 108. Otsuka Pharmaceutical Business Overview Table 109. Otsuka Pharmaceutical Antipsychotic DrugProduct Table 110. Otsuka Pharmaceutical Revenue in Antipsychotic Drug Business (2017-2022) & (US$ Million) Table 111. Otsuka Pharmaceutical Recent Development Table 112. Vanda Pharmaceuticals Company Detail Table 113. Vanda Pharmaceuticals Business Overview Table 114. Vanda Pharmaceuticals Antipsychotic DrugProduct Table 115. Vanda Pharmaceuticals Revenue in Antipsychotic Drug Business (2017-2022) & (US$ Million) Table 116. Vanda Pharmaceuticals Recent Development Table 117. H.Lundbeck Company Detail Table 118. H.Lundbeck Business Overview Table 119. H.Lundbeck Antipsychotic DrugProduct Table 120. H.Lundbeck Revenue in Antipsychotic Drug Business (2017-2022) & (US$ Million) Table 121. H.Lundbeck Recent Development Table 122. Organon Company Detail Table 123. Organon Business Overview Table 124. Organon Antipsychotic DrugProduct Table 125. Organon Revenue in Antipsychotic Drug Business (2017-2022) & (US$ Million) Table 126. Organon Recent Development Table 127. Hansoh Company Detail Table 128. Hansoh Business Overview Table 129. Hansoh Antipsychotic DrugProduct Table 130. Hansoh Revenue in Antipsychotic Drug Business (2017-2022) & (US$ Million) Table 131. Hansoh Recent Development Table 132. Hengrui Company Detail Table 133. Hengrui Business Overview Table 134. Hengrui Antipsychotic DrugProduct Table 135. Hengrui Revenue in Antipsychotic Drug Business (2017-2022) & (US$ Million) Table 136. Hengrui Recent Development Table 137. Nhwa Group Company Detail Table 138. Nhwa Group Business Overview Table 139. Nhwa Group Antipsychotic DrugProduct Table 140. Nhwa Group Revenue in Antipsychotic Drug Business (2017-2022) & (US$ Million) Table 141. Nhwa Group Recent Development Table 142. Yangtze River Pharmaceutical Group Company Detail Table 143. Yangtze River Pharmaceutical Group Business Overview Table 144. Yangtze River Pharmaceutical Group Antipsychotic DrugProduct Table 145. Yangtze River Pharmaceutical Group Revenue in Antipsychotic Drug Business (2017-2022) & (US$ Million) Table 146. Yangtze River Pharmaceutical Group Recent Development Table 147. Research Programs/Design for This Report Table 148. Key Data Information from Secondary Sources Table 149. Key Data Information from Primary Sources List of Figures Figure 1. Global Antipsychotic Drug Market Share by Type: 2021 VS 2028 Figure 2. First Generation Antipsychotics Drug Features Figure 3. Second Generation Antipsychotics Drug Features Figure 4. Third generation Antipsychotics Drug Features Figure 5. Global Antipsychotic Drug Market Share by Application in 2021 & 2028 Figure 6. Bipolar I Disorder Case Studies Figure 7. Schizophrenia Case Studies Figure 8. Schizoaffective Disorder Case Studies Figure 9. Others Case Studies Figure 10. Antipsychotic Drug Report Years Considered Figure 11. Global Antipsychotic Drug Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global Antipsychotic Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Antipsychotic Drug Market Share by Region: 2021 VS 2028 Figure 14. Global Antipsychotic Drug Market Share by Players in 2021 Figure 15. Global Top Antipsychotic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antipsychotic Drug as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Antipsychotic Drug Revenue in 2021 Figure 17. North America Antipsychotic Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. North America Antipsychotic Drug Market Share by Country (2017-2028) Figure 19. United States Antipsychotic Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Canada Antipsychotic Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Antipsychotic Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Antipsychotic Drug Market Share by Country (2017-2028) Figure 23. Germany Antipsychotic Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. France Antipsychotic Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. U.K. Antipsychotic Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Italy Antipsychotic Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Russia Antipsychotic Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Nordic Countries Antipsychotic Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Antipsychotic Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Antipsychotic Drug Market Share by Region (2017-2028) Figure 31. China Antipsychotic Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Japan Antipsychotic Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. South Korea Antipsychotic Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Southeast Asia Antipsychotic Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. India Antipsychotic Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Australia Antipsychotic Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Antipsychotic Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Antipsychotic Drug Market Share by Country (2017-2028) Figure 39. Mexico Antipsychotic Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Brazil Antipsychotic Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Antipsychotic Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Antipsychotic Drug Market Share by Country (2017-2028) Figure 43. Turkey Antipsychotic Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Saudi Arabia Antipsychotic Drug Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Johnson & Johnson Revenue Growth Rate in Antipsychotic Drug Business (2017-2022) Figure 46. Pfizer Revenue Growth Rate in Antipsychotic Drug Business (2017-2022) Figure 47. Eli Lilly Revenue Growth Rate in Antipsychotic Drug Business (2017-2022) Figure 48. Bristol Myers Squibb Revenue Growth Rate in Antipsychotic Drug Business (2017-2022) Figure 49. AstraZeneca Revenue Growth Rate in Antipsychotic Drug Business (2017-2022) Figure 50. Sumitomo Dainippon Pharma Revenue Growth Rate in Antipsychotic Drug Business (2017-2022) Figure 51. Allergan Revenue Growth Rate in Antipsychotic Drug Business (2017-2022) Figure 52. Novartis Revenue Growth Rate in Antipsychotic Drug Business (2017-2022) Figure 53. Cardinal Health Revenue Growth Rate in Antipsychotic Drug Business (2017-2022) Figure 54. Sun Pharmaceutical Industries Revenue Growth Rate in Antipsychotic Drug Business (2017-2022) Figure 55. GlaxoSmithKline Revenue Growth Rate in Antipsychotic Drug Business (2017-2022) Figure 56. Sanis Health Revenue Growth Rate in Antipsychotic Drug Business (2017-2022) Figure 57. Qilu Pharmaceutical Revenue Growth Rate in Antipsychotic Drug Business (2017-2022) Figure 58. Otsuka Pharmaceutical Revenue Growth Rate in Antipsychotic Drug Business (2017-2022) Figure 59. Vanda Pharmaceuticals Revenue Growth Rate in Antipsychotic Drug Business (2017-2022) Figure 60. H.Lundbeck Revenue Growth Rate in Antipsychotic Drug Business (2017-2022) Figure 61. Organon Revenue Growth Rate in Antipsychotic Drug Business (2017-2022) Figure 62. Hansoh Revenue Growth Rate in Antipsychotic Drug Business (2017-2022) Figure 63. Hengrui Revenue Growth Rate in Antipsychotic Drug Business (2017-2022) Figure 64. Nhwa Group Revenue Growth Rate in Antipsychotic Drug Business (2017-2022) Figure 65. Yangtze River Pharmaceutical Group Revenue Growth Rate in Antipsychotic Drug Business (2017-2022) Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research

Can't find what you're looking for about this report?

Submit Query

Go to contact form

Phone Number

1-302-273-0910
Chat with us